1887

oa Central African Journal of Medicine - The laboratory and clinical monitoring of lithium treatment in manic-depressive patients

Volume 29, Issue 4
  • ISSN : 0008-9176

 

Abstract

Lithium has proved to be a very useful drug in the treatment and prophylaxis of manic depressive illness. Its use requires constant monitoring to ensure that patients are not receiving inadequate or toxic doses. The patient should be warned that a good water and salt balance must be maintained and the prescribed dosage should never be exceeded. If a dose is missed for some reason no attempt should be made to 'catch up' by taking a double dose. If a patient is having a general anaesthetic the preoperative fast should be supplemented with adequate intravenous fluids to ensure adequate salt and water balance. Patients should also be warned against discontinuing the drug when they feel that their mania has been 'cured' as .rapid relapse and further hospitalization is likely to occur.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/CAJM/29/4/AJA00089176_2186
1983-04-01
2019-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error